BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 23696923)

  • 1. KAI1/CD82 and cyclin D1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma.
    Zhang B; Liu W; Li L; Lu J; Liu M; Sun Y; Jin D
    Int J Clin Exp Pathol; 2013; 6(6):1060-7. PubMed ID: 23696923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KAI1/CD82 and MRP1/CD9 serve as markers of infiltration, metastasis, and prognosis in laryngeal squamous cell carcinomas.
    Zhang BH; Liu W; Li L; Lu JG; Sun YN; Jin DJ; Xu XY
    Asian Pac J Cancer Prev; 2013; 14(6):3521-6. PubMed ID: 23886139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of cancer stem cells marked by CD133 and KAI1/CD82 expression in laryngeal squamous cell carcinoma.
    Yu L; Zhou L; Wu S; Gong X; Feng Z; Ma L; Zhu B; Yao N; Wang D; Dong H
    World J Surg Oncol; 2014 Apr; 12():118. PubMed ID: 24758564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cyclin D1 and E-cadherin expression in laryngeal squamous cell carcinoma.
    Ahmed RA; Shawky Ael-A; Hamed RH
    Pathol Oncol Res; 2014 Jul; 20(3):625-33. PubMed ID: 24470282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.
    Protzel C; Kakies C; Kleist B; Poetsch M; Giebel J
    Virchows Arch; 2008 Apr; 452(4):369-75. PubMed ID: 18305955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the correlation of KAI1/CD82, CD44, MMP7 and β-catenin in the prediction of prognosis and metastasis in colorectal carcinoma.
    Wu Q; Yang Y; Wu S; Li W; Zhang N; Dong X; Ou Y
    Diagn Pathol; 2015 Sep; 10():176. PubMed ID: 26408312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma.
    Zheng Z; Tian R; Wang P
    World J Surg Oncol; 2017 Nov; 15(1):211. PubMed ID: 29187211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the correlation of vasculogenic mimicry, Notch4, DLL4, and KAI1/CD82 in the prediction of metastasis and prognosis in non-small cell lung cancer.
    Wang Y; Yang R; Wang X; Ci H; Zhou L; Zhu B; Wu S; Wang D
    Medicine (Baltimore); 2018 Dec; 97(52):e13817. PubMed ID: 30593175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of Cyclin D1, FGF3 and p21 protein expression in laryngeal squamous cell carcinoma.
    Jovanovic IP; Radosavljevic GD; Simovic-Markovic BJ; Stojanovic SP; Stefanovic SM; Pejnovic NN; Arsenijevic NN
    J BUON; 2014; 19(4):944-52. PubMed ID: 25536600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated expression of yes‑associated protein is associated with the malignant status and prognosis of laryngeal squamous cell carcinoma.
    Pan C; Du Z; Cai Z; Liu Y; Sun Y; Chen J; Tong T; Chen Q; Zhou L; Bing D; Tao Y; Chu H
    Mol Med Rep; 2017 Oct; 16(4):4934-4940. PubMed ID: 28791393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical significance of Stat3 and Cyclin D1 expression in laryngeal squamous cell carcinoma].
    Wang L; Duan X; Tang X; Shao Y; Zhao R; Qian X; Gao X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Nov; 25(21):966-9. PubMed ID: 22260073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical significance of CD82/KAI1 and E-cadherin in non-small cell lung cancer.
    Shiwu WU; Lan Y; Wenqing S; Lei Z; Yisheng T
    Arch Iran Med; 2012 Nov; 15(11):707-12. PubMed ID: 23102249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of metastasis suppressor gene KAI1/CD82 in cervical squamous cell carcinoma and its clinical significance].
    Xiong Y; Liang LZ; Yan XJ; Yuan SH; Wei M
    Ai Zheng; 2005 Jan; 24(1):110-5. PubMed ID: 15642213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma.
    Yang L; Wang H; Wang Y; He Z; Chen H; Liang S; He S; Wu S; Song L; Chen Y
    Oncotarget; 2016 May; 7(22):31878-91. PubMed ID: 26992242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of CD82/KAI1 and HIF-1α in non-small cell lung cancer and their relationship to vasculogenic mimicry].
    Wu S; Cheng Z; Yu L; Song W; Tao Y
    Zhongguo Fei Ai Za Zhi; 2011 Dec; 14(12):918-25. PubMed ID: 22152691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of KAI1 gene in human laryngeal carcinoma and its clinical significance].
    Bai WL; Ren Z; Pan ZM; Gao H
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):289-91. PubMed ID: 15996322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motility-related protein (MRP-1/CD9) and KAI1/CD82 expression inversely correlate with lymph node metastasis in oesophageal squamous cell carcinoma.
    Uchida S; Shimada Y; Watanabe G; Li ZG; Hong T; Miyake M; Imamura M
    Br J Cancer; 1999 Mar; 79(7-8):1168-73. PubMed ID: 10098753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CyclinD1 and underexpression of p16 correlate with lymph node metastases in laryngeal squamous cell carcinoma in Chinese patients.
    Fu ZJ; Ma ZY; Wang QR; Lei DP; Wang R; Liu CX; Pan XL
    Clin Exp Metastasis; 2008; 25(8):887-92. PubMed ID: 18787961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the correlation between the cyclin D1 and laryngeal squamous cell carcinoma].
    Chen J; Jin X; Zhou L
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 1999 Jun; 13(6):268-70. PubMed ID: 12563983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.